USPTO serial 99200304
SEQURNA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 17, 2026
- Examiner
- NEPTUNE, EVONNE MARIE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SEQURNA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Charlene Azema
Charlene Azema Knobbe, Martens, Olson & Bear, LLP2040 Main Street, 14th FloorIrvine, CA 92614United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents for medical research; Diagnostic reagents for scientific use; Reagents for research purposes | ACTIVE | — |
| 005 | Reagents for medical use; Clinical diagnostic reagents for medical use; Diagnostic reagents for medical use; Reagents for use with analyzers for medical purposes; Diagnostic biomarker reagents for medical purposes; Clinical medical reagents; Reagent paper for medical purposes | ACTIVE | — |
| 010 | Medical apparatus and instruments, namely, vials containing RNase inhibitors used for RNA sequencing; Apparatus for use in medical analysis, namely, vials containing RNase inhibitors used for RNA sequencing; Testing apparatus for medical purposes; Diagnostic apparatus for medical purposes, namely, vials containing RNase inhibitors used for RNA sequencing; Apparatus for DNA and RNA exams for medical purposes; Capillary tubes for delivering reagents for medical use | ACTIVE | — |
| 042 | Scientific, medical and pharmaceutical research and development services; Scientific laboratory services; Medical research laboratory services; Laboratory research services relating to molecular biology and biomedicine; Medical and scientific consulting services in the fields of molecular biology and biomedicine; Providing medical and scientific research information in the field of molecular biology and biomedicine; Pharmaceutical and scientific research and development; Laboratory diagnostics, namely, medical analysis services relating to the diagnosis and treatment of persons provided by medical laboratories; Information, advisory and consultancy services relating to the aforesaid | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SEQURNA AB
- Other trademarks owned by SEQURNA AB
- Other trademarks owned by SEQURNA AB
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named SEQURNA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 17, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 17, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 27, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 27, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 21, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 2, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 2, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 2, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 2, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 2, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 13, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 13, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 13, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 10, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 1, 2025 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Oct 1, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 23, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 23, 2025 | NWAP | NEW APPLICATION ENTERED | — |